His primary scientific interests are in Myocardial infarction, Internal medicine, Percutaneous coronary intervention, Cardiology and Surgery. His study on Conventional PCI and Cardiogenic shock is often connected to In patient as part of broader study in Myocardial infarction. He has researched Percutaneous coronary intervention in several fields, including Angioplasty, Heart failure, MEDLINE and Medical emergency.
His research investigates the connection between Cardiology and topics such as Confidence interval that intersect with problems in Complication. Jens Flensted Lassen usually deals with Stenosis and limits it to topics linked to Angiography and Fractional flow reserve. His Stent research incorporates themes from Coronary artery disease, Artery and Acute coronary syndrome.
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Surgery. His Hazard ratio, Coronary artery disease, Sirolimus and Mace study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines. His work focuses on many connections between Cardiology and other disciplines, such as Coronary stent, that overlap with his field of interest in Intravascular ultrasound.
His Myocardial infarction research includes elements of Electrocardiography and Thrombosis. His biological study deals with issues like Conventional PCI, which deal with fields such as Reperfusion therapy and Intensive care medicine. His study in Stent, Randomized controlled trial and Clinical endpoint are all subfields of Surgery.
Jens Flensted Lassen spends much of his time researching Internal medicine, Percutaneous coronary intervention, Myocardial infarction, Cardiology and Conventional PCI. His Percutaneous coronary intervention research includes themes of Coronary artery disease, Radiology, Angioplasty and MEDLINE. The concepts of his Myocardial infarction study are interwoven with issues in Stent, Clinical endpoint, Randomized controlled trial and Surgery.
As a part of the same scientific study, he usually deals with the Stent, concentrating on Confidence interval and frequently concerns with Pediatrics and Logistic regression. His work on Sirolimus is typically connected to Biodegradable polymer as part of general Surgery study, connecting several disciplines of science. His research on Conventional PCI also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps).
Bjarne L Nørgaard;Jonathon Leipsic;Sara Gaur;Sujith Seneviratne.
Journal of the American College of Cardiology (2014)
Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study
Terje K. Steigen;Michael Maeng;Rune Wiseth;Andrejs Erglis.
Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial
Hans Erik Bøtker;Rajesh Kharbanda;Michael R Schmidt;Morten Bøttcher.
The Lancet (2010)
System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention
Christian Juhl Terkelsen;Jacob Thorsted Sørensen;Michael Maeng;Lisette Okkels Jensen.
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
Timo Mäkikallio;Niels R Holm;Mitchell Lindsay;Mark S Spence.
The Lancet (2016)
Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction
Gilles Montalescot;Arnoud W. van 't Hof;Frédéric Lapostolle;Johanne Silvain.
The New England Journal of Medicine (2014)
Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort
Christian Juhl Terkelsen;Jens Flensted Lassen;Bjarne Linde Nørgaard;Jens Christian Gerdes.
European Heart Journal (2005)
Classification of coronary artery bifurcation lesions and treatments: time for a consensus!
Yves Louvard;Martyn Thomas;Vladimir Dzavik;David Hildick-Smith.
Catheterization and Cardiovascular Interventions (2008)
Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting The Nordic-Baltic Bifurcation Study III
Matti Niemelä;Kari Kervinen;Andrejs Erglis;Niels R. Holm.
Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions
Lisette Okkels Jensen;Michael Maeng;Anne Kaltoft;Per Thayssen.
Journal of the American College of Cardiology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: